Navigation Links
Actavis Announces 42% Increase to $2.01 in Second Quarter 2013 Non-GAAP Earnings Per Share
Date:7/25/2013

nue was $649.8 million, up 209 percent from the prior year, also primarily a result of the inclusion of legacy Actavis product sales.  Net revenue consists of sales of generics, branded generics and OTC products in the Americas (U.S., Canada and Latin America), Europe (Europe, Russia, CIS and Turkey), and the Middle East, Africa, Australia and Asia Pacific (collectively, MEAAP).

Actavis Pharma R&D investment for the second quarter 2013 increased to $103.7 million, and selling and marketing expenses for the second quarter 2013 increased to $160.9 million, primarily as a result of the inclusion of legacy Actavis results.

Actavis Pharma's adjusted gross margin increased from 47.6 percent in the second quarter of 2012 to 51.9 percent in the second quarter of 2013, primarily due to Anda's distribution of Lidoderm®, increased margins on our generic version of Concerta® as a result of our contractual arrangement with Ortho-McNeil-Janssen and higher other revenue.

 Specialty Brands Segment InformationThree Months EndedSix Months EndedJune 30,June 30,(Unaudited; $ in millions)2013201220132012Product sales

$
26.9$
.9$
243.1$
93.8Other revenue

17.918.432.435.1Net revenue

144.8119.3275.5228.9Operating expenses:Cost of sales

34.428.764.254.5Research and development

31.925.965.258.3Selling and marketing

47.042.590.690.2Segment contribution

$
31.5$
22.2$
55.5$
25.9Segment margin

21.8%18.6%20.1%11.3%Gross profit

$
.4$
90.6$
211.3$
74.4Gross margin

76.2%75.9%76.7%76.2%Actavis Specialty Brands net revenue increased 21 percent to $144.8 million in the second quarter. The increase was primarily due to higher sales of key promoted products including Generess® Fe, Rapaflo®, Crinone® and the addition of Kadian®

Actavis S
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
10. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
11. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic USA vs. ... will face the Australia Women's National Team in conjunction with their Victory Tour to celebrate ... Carli Lloyd from the USA team was awarded the Golden Ball as the best player ...
(Date:7/31/2015)... ... July 31, 2015 , ... Eldermark ... for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The ... post-acute care providers understand the benefits of using medication management technologies . ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a ... , What is HITaaS? Health IT as a Service (HITaaS) is a Healthcare dedicated ... a service (SaaS). , HITaaS manages all aspects of infrastructure, security, ...
(Date:7/31/2015)... York (PRWEB) , ... July 31, 2015 , ... Physical therapy for ... limits the patient's quality of life. It keeps the patient from doing what they want ... and may have a hard time using the stairs. The patient's exercise regime may be ...
(Date:7/31/2015)... ... July 31, 2015 , ... New Energy Works Timberframers invites the public to ... August 15th, 2015 from 9am – 12pm. Timber frame raisings are special, ... entire community as the culmination of months of effort, planning, fundraising, and dreaming takes ...
Breaking Medicine News(10 mins):Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3
... * concentrated Tylenol(R) Infants, Drops Plus ... * PediaCare(R) ... Consumer,Healthcare, a division of McNeil-PPC, Inc., announced today that the,company is ... used as directed, these medicines are generally,recognized as safe and effective. ...
... 11 ALOKA Co., Ltd., a pioneer in ... of Masanobu Tada as President, and Carlos Faustmann ... AG, the company,s,wholly-owned European headquarters in Zug, Switzerland, ... the Global Marketing of the company as,general manager ...
... Passage of Plan to Give Access to Affordable Health ... week after Cover,All Pennsylvanians, the centerpiece of his "Prescription ... Rendell today held a,town meeting in Erie as part ... will highlight the need to lower health care costs,and ...
... virus (MMTV) - which causes mammary cancer in mice - ... week shows. The study, published in the online open access ... be involved in causing human breast cancer. , The idea ... around for over 50 years. In the 1990s, researchers detected ...
... Avicena Group,Inc. (OTC Bulletin Board: AVGO), a late-stage ... neurodegenerative,disorders, announced today the appointment of its C.E.O., ... of the Company,s,Board of the Directors. Dr. Tsao- ... Board to focus his time on other business,ventures. ...
... 10 HealthShares(TM) Inc., an investment,company with a family ... has approved the transfer of its 19 currently NYSE-listed,HealthShares ... accordance with NYSE Euronext requirement to transfer of all ... expected to be completed prior to,October 31, 2007. The ...
Cached Medicine News:Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3Health News:ALOKA Appoints New Management in Europe 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 3Health News:Mouse mammary tumor virus can replicate in human cells 2Health News:Avicena Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: